147 related articles for article (PubMed ID: 11108308)
1. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg).
Grigg AP; McLachlan R; Zaja J; Szer J
Bone Marrow Transplant; 2000 Nov; 26(10):1089-95. PubMed ID: 11108308
[TBL] [Abstract][Full Text] [Related]
2. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
[TBL] [Abstract][Full Text] [Related]
3. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
[TBL] [Abstract][Full Text] [Related]
4. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling.
Anserini P; Chiodi S; Spinelli S; Costa M; Conte N; Copello F; Bacigalupo A
Bone Marrow Transplant; 2002 Oct; 30(7):447-51. PubMed ID: 12368957
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting gonadal function after bone marrow transplantation during childhood.
Couto-Silva AC; Trivin C; Thibaud E; Esperou H; Michon J; Brauner R
Bone Marrow Transplant; 2001 Jul; 28(1):67-75. PubMed ID: 11498747
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
[TBL] [Abstract][Full Text] [Related]
7. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
8. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth.
Baker BW; Wilson CL; Davis AL; Spearing RL; Hart DN; Heaton DC; Beard ME
Bone Marrow Transplant; 1991 Jan; 7(1):43-7. PubMed ID: 2043877
[TBL] [Abstract][Full Text] [Related]
9. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
[TBL] [Abstract][Full Text] [Related]
10. Relationships between serum hormone levels and semen quality among men from an infertility clinic.
Meeker JD; Godfrey-Bailey L; Hauser R
J Androl; 2007; 28(3):397-406. PubMed ID: 17135633
[TBL] [Abstract][Full Text] [Related]
11. Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies.
Kyriacou C; Kottaridis PD; Eliahoo J; McKeag N; Bomford J; McGarrigle HH; Linch DC; Mackinnon S; Chatterjee R
Bone Marrow Transplant; 2003 Jan; 31(1):45-50. PubMed ID: 12621506
[TBL] [Abstract][Full Text] [Related]
12. Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan.
Panasiuk A; Nussey S; Veys P; Amrolia P; Rao K; Krawczuk-Rybak M; Leiper A
Br J Haematol; 2015 Sep; 170(5):719-26. PubMed ID: 25974284
[TBL] [Abstract][Full Text] [Related]
13. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
14. Fertility, pregnancies and offspring complications after bone marrow transplantation.
Hinterberger-Fischer M; Kier P; Kalhs P; Marosi C; Geissler K; Schwarzinger I; Pabinger I; Huber J; Spona J; Kolbabek H
Bone Marrow Transplant; 1991 Jan; 7(1):5-9. PubMed ID: 1904290
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
16. Recovery of spermatogenesis following bone marrow transplantation.
Jacob A; Barker H; Goodman A; Holmes J
Bone Marrow Transplant; 1998 Aug; 22(3):277-9. PubMed ID: 9720742
[TBL] [Abstract][Full Text] [Related]
17. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305
[TBL] [Abstract][Full Text] [Related]
18. Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.
Bleyzac N; Souillet G; Magron P; Janoly A; Martin P; Bertrand Y; Galambrun C; Dai Q; Maire P; Jelliffe RW; Aulagner G
Bone Marrow Transplant; 2001 Oct; 28(8):743-51. PubMed ID: 11781625
[TBL] [Abstract][Full Text] [Related]
19. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
20. [The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
Zhu K; Xu Y; Wu D; Xu X; Huang L
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):403-5. PubMed ID: 11877010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
